Categories: Manufacturers (D)

Intas Pharma Ltd, Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009, Gujarat, India

Company Name : Intas Pharma Ltd

Address : Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009, Gujarat, India

Tel No: 91 79 6652 3100 / 2657 6655

Email : generalqueries@intaspharma.com, productqueries@intaspharma.com

Website : http://www.intaspharma.com/

Company Profile

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.

Intas’ success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R & D, Biotechnology and global operations over three decades. As of 31st of March 2013, Intas has grown to be a ~$650 million* organization with a revenue growth over 30% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. Intas is now ranked as the 12th largest pharmaceutical company in the domestic market (as per IMS Health India, Secondary Stockist Audit (SSA), April, 2014 MAT).

In the domestic market, Intas is the 5th largest corporate in Indian Chronic Pharma Market with a market share of 4.85%. It also has presence in cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management as well as other therapeutic segments.

Besides rapidly growing domestic prominence, Intas is also present in more than 70 countries worldwide with robust sales, marketing and distribution infrastructure in markets like North America, Europe, Central & Latin America, Africa, Australia, New Zealand, Asia – Pacific as well as CIS and MENA countries.

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

3 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

4 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

4 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

5 days ago